Author Escudé Viñals, Laura |
Abstract The development of cancer vaccines as an immunotherapy is a great promising alternative towards cancer treatments, and, specifically, mRNA-based vaccines are a recently new and appealing approach. However, in order to perform the proper laboratory research and arrive to a preclinical state, some challenges need to be faced; the specificity of the antigen in the cancer cells and the synthesis of mRNA. Although the mRNA can be obtained through a commercial producer, in order to analyze different antigens at the same time and evaluate the efficacy of the system, a platform for its synthesis in the laboratory needs to be optimized and prepared. |
|
Director Fornaguera Puigvert, Cristina |
||
Degree IQS SE - Undergraduate Program in Biotechnology |
||
Date 2022-06-07
|